UBS maintains a 'Buy' in Auxilium Pharmaceuticals (NASDAQ: AUXL) price target of $34.00 (from $32.00).

Analyst, Ami Fadia, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE